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Corynebacterium
pseudogenitalium
Urinary Tract
Infection
To the Editor: A 64-year-old man
was admitted to the urology depart-
ment of Cochin Hospital in Paris,
France, for acute urinary retention. He
had a history of recurrent urolithiasis
and undocumented urinary tract
symptoms. At admission, a urethral
catheter was inserted, and a plain radi-
ograph showed 2 bladder stones and
milk of calcium calcifications. Three
days later, he underwent extracorpo-
real shock wave lithotripsy treatment,
and empiric antimicrobial drug thera-
py with intravenous ceftriaxone, 1
g/day for 3 days, was administered.
Three consecutive urinalyses showed
a pH of 9, crystals of struvite, hema-
turia, and 105 leukocytes/mL. Gram-
positive rods with rounded ends and
nonparallel sides, arranged in pal-
isades or in V shapes, were observed,
which suggested the presence of
corynebacteria. Urine cultures were
positive and yielded a pure culture of
105 CFU/mLof Corynebacterium spp. 
The isolated strain showed slight
growth after 24 or 48 h of incubation
on horse blood agar medium but
abundant growth on the same medium
containing 1% Tween 80 under aero-
bic conditions (5% CO2). Colonies
were white, opaque, smooth, convex,
and nonhemolytic. This lipid-requir-
ing strain was catalase positive and
strongly urease positive. Testing with
the API-Coryne strip (bioMérieux,
Marcy l’Etoile, France) showed that
the strain was nitrate-reduction posi-
tive and produced acid from glucose,
ribose, sucrose, and maltose.
However, this strain, which was des-
ignated CCH052683, did not
hydrolyze gelatin or esculin. It was
identified as Corynebacterium group
F1 (the corresponding numeric profile
of the gallery API-Coryne was
3001325).
The strain was correctly identified
to the species level as Corynebac-
terium pseudogenitalium by using
polymerase chain reaction and
sequencing 16 rRNA as previously
described (1,2). Comparison of 785
nucleotides (546–1,331) gave a 16S
rDNA similarity value of 99.9%
between the sequences of the isolated
strain and C. pseudogenitaliumATCC
33039/NCTC11860 (European Mole-
cular Biology Laboratory accession
no. X81872).
The strain was sensitive to peni-
cillin, ampicillin, gentamicin, rifam-
pin, vancomycin, teicoplanin, tetracy-
cline, sulfamethoxazole, trimetho-
prim, fusidic acid, ciprofloxacin, and
norfloxacin and resistant to erythro-
mycin, lincomycin, and nitrofuran-
toin. Ceftriaxone was replaced by nor-
floxacin (400 mg twice a day) for 1
month. The patient improved and
remained healthy 6 months after ther-
apy. 
Nondiphtheric corynebacteria are
of increasing importance. They have
been observed in human specimens,
and many new taxa of coryneform
bacteria have been described (3).
Interest in their taxonomy is increas-
ing, and molecular, phenotypic, and
biochemical analyses have resulted in
the reclassification of this genus (3).
C. pseudogenitalium was described in
1979 by Furness et al. (4) for
lipophilic corynebacteria isolated
from urinary tract and was not consid-
ered a pathogen, in contrast to C. gen-
italium. However, these 2 species
were not included in the official list of
recognized species. 
C. pseudogenitalium was divided
into 5 types based on biochemical pat-
terns, and strains of the type C-5 were
differentiated from other types on the
basis of urease production. The bio-
chemical and physiologic characteris-
tics of this C-5 type were similar of
those of the coryneform group F-1
described by the Centers for Disease
Control and Prevention (CDC). In
1995, a comprehensive study on
lipophilic corynebacteria demonstrat-
ed by DNA-DNA hybridization the
similarity between a reference strain
of C. pseudogenitalium type C-5 and
reference strains of the CDC coryne-
form group F-1 (1). The CDC group
F-1 make up 2 genomic groups at the
species level. As shown by 16S rDNA
gene comparisons, isolate CCH0-
52683 belongs to the genomic group,
including a reference strain of C.
pseudogenitalium type C-5 ATCC
33039 (CCUG 27540, sequence
X81872) and a reference strain of
CDC group F-1 (CDC G4330,
sequence X81905) (Figure). The other
genomic group of CDC group F-1 is
represented by strain CDC G5911
(sequence X81904). The molecular
genetic investigations identified our
isolate as C. pseudogenitalium and
placed it in 1 of the 2 genomic groups
of CDC group F-1, which cannot be
differentiated by biochemical tests
(1). 
The pathogenicity of this bacteri-
um was associated with strong urease
activity. This activity is similar to that
of other urease-positive microorgan-
isms, such as C. urealyticum and
Proteus spp. (5,6), which infect the
urinary tract. Unfortunately, the blad-
der stones were not analyzed after
extracorporeal shock wave lithotripsy
treatment. The C.  pseudogenitalium
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isolate was sensitive to most antimi-
crobial drugs, particularly β-lactams,
aminoglycosides, and quinolones.
Thus, urinary tract infections caused
by this species of bacteria respond
more readily to treatment than those
caused by multidrug-resistant C.  ure-
alyticum (3).
In conclusion, we show that C.
pseudogenitalium  (CDC coryneform
group F-1) can cause urinary tract
infection (7) and produce urease, and
like C.  urealyticum, cause stone for-
mation in humans. Thus, urease-posi-
tive microorganisms isolated by uri-
nalysis that shows urinary alkaliniza-
tion and struvite and pyuria crystal-
lization should be considered patho-
genic. Our results also confirm the
difficulty in phenotypic identification
of these strains and the need to use a
molecular approach to identify
coryneform bacteria with clinical rel-
evance.
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Puumala Virus RNA
in Patient with
Multiorgan Failure
To the Editor: The hantaviruses
(genus  Hantavirus, family Bunya-
viridae) include human pathogens and
occur worldwide (1). In Western and
Central Europe, the predominant
serotype is Puumala virus (PUUV),
which causes epidemic nephropathy.
We report the first Austrian patient
with reverse transcription–poly-
merase chain reaction (RT-PCR)–con-
firmed PUUV infection and, to our
knowledge, the first detection of
PUUV-specific RNA in bone marrow.
On April 27, 2004, a previously
healthy 52-year-old bus driver
stopped his bus because of visual dis-
turbance, dizziness, headache, and
weakness in his legs; he then lost con-
sciousness for a few minutes. He was
seen at the neurology emergency serv-
ice and subsequently admitted to the
university hospital in Graz. He
smoked tobacco, drank beer on the
weekends, and cleaned his bus in the
garage daily. The patient showed
slight paresis of the right leg, nystag-
mus, cognitive deficit, and retrograde
amnesia. Laboratory tests showed
increases in (normal values are shown
in parentheses) C-reactive protein
(CRP) 40 mg/L (<9), creatine kinase
(CK) 224 U/L (<170), lactate dehy-
drogenase (LDH) 244 U/L (<240),
and myoglobin 416 ng/mL (<90).
Cerebrospinal fluid showed elevated
protein of 60 mg/dL (<45) but no
other abnormalities. Results of
computed tomographic scan of the
brain and chest radiograph were nor-
mal. Because of increasing CRP (115
mg/L), empiric antimicrobial therapy
with pipera-cillin/tazobactam was
started. During an electroencephalo-
gram on April 29, the patient deterio-
rated and was admitted to the inten-
sive care unit for respiratory failure
with a partial oxygen pressure of 40
mm Hg; he required intubation and
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Figure. Unrooted tree showing phylogenetic relationships of Corynebacterium pseudogen-
italium CCH052683 and other members of the genus Corynebacterium. The tree was con-
structed by using the DNAstar program (DNAstar Inc., Madison, WI, USA) (Clustal
method) and based on a comparison of 785 (546–1,331) nucleotides. European Molecular
Biology Laboratory sequence accession numbers are shown. The scale bar shows the
percentage sequence divergence. Dotted line indicates a distant phylogenetic group for
which the scale is not applicable.